Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Capital Employed (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Return on Capital Employed for 4 consecutive years, with 0.14% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed rose 24.0% to 0.14% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.14%, a 24.0% increase, with the full-year FY2024 number at 0.61%, down 25.0% from a year prior.
  • Return on Capital Employed was 0.14% for Q3 2025 at Century Therapeutics, down from 0.11% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.1% in Q1 2025 to a low of 0.57% in Q4 2024.
  • A 4-year average of 0.32% and a median of 0.33% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -17bps in 2024, then soared 33bps in 2025.
  • Century Therapeutics' Return on Capital Employed stood at 0.29% in 2022, then tumbled by -42bps to 0.41% in 2023, then crashed by -41bps to 0.57% in 2024, then surged by 76bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Return on Capital Employed are 0.14% (Q3 2025), 0.11% (Q2 2025), and 0.1% (Q1 2025).